BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/9/2026 9:23:56 AM | Browse: 0 | Download: 0
 |
Received |
|
2025-11-06 06:53 |
|
Peer-Review Started |
|
2025-11-06 06:53 |
|
First Decision by Editorial Office Director |
|
2025-12-30 05:45 |
|
Return for Revision |
|
2025-12-30 05:45 |
|
Revised |
|
2026-01-02 04:31 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-02-04 02:52 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-02-04 07:07 |
|
Articles in Press |
|
2026-02-04 07:07 |
|
Edit the Manuscript by Language Editor |
|
2026-02-13 16:03 |
|
Typeset the Manuscript |
|
2026-05-25 02:08 |
|
Publish the Manuscript Online |
|
2026-06-09 09:23 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Opinion Review |
| Article Title |
Transcatheter arterial chemoembolization plus lenvatinib toward precision prognostication for unresectable hepatocellular carcinoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Yu-Han Yang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Yu-Han Yang, West China Hospital, Sichuan University, No. 17 People’s South Road, Chengdu 6100041, Sichuan Province, China. yyh_1023@163.com |
| Key Words |
Hepatocellular carcinoma; Transcatheter arterial chemoembolization; Lenvatinib; Prognostic model; Nomogram; Survival prediction |
| Core Tip |
We summarized risk factors including number of tumors, microvascular invasion, Eastern Cooperative Oncology Group performance status, and Child-Pugh stage, and protective factor (triple therapy) for unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization plus lenvatinib, constructed and validated prognostic models. In the validation set, area under the curve values of overall survival and progression-free survival, calibration curves, confirmed their good performance, providing guidance for clinical practice. |
| Publish Date |
2026-06-09 09:23 |
| Citation |
Yang YH. Transcatheter arterial chemoembolization plus lenvatinib toward precision prognostication for unresectable hepatocellular carcinoma. World J Gastrointest Oncol 2026; 18(6): 116250
|
| URL |
https://www.wjgnet.com/1948-5204/full/v18/i6/116250.htm |
| DOI |
https://doi.org/10.4251/wjgo.v18.i6.116250 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
